AbbVie Inc. financial data

Symbol
ABBV on NYSE
Industry
Pharmaceutical Preparations
Location
1 North Waukegan Road, North Chicago, Illinois
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 89 % -4.81%
Quick Ratio 10.6 % -11.6%
Return On Equity 57.1 % -2.16%
Return On Assets 3.8 % -39.7%
Operating Margin 22.3 % -28.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.77B shares +0.07%
Entity Public Float 236B USD -12.2%
Weighted Average Number of Shares Outstanding, Basic 1.77B shares +0.06%
Weighted Average Number of Shares Outstanding, Diluted 1.77B shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 55B USD -1.83%
Costs and Expenses 42.7B USD +10.6%
Operating Income (Loss) 12.3B USD -29.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.07B USD -32.4%
Income Tax Expense (Benefit) 1.72B USD -2.39%
Net Income (Loss) Attributable to Parent 5.34B USD -38.5%
Earnings Per Share, Basic 3 USD/shares -38.5%
Earnings Per Share, Diluted 3 USD/shares -38.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.1B USD +49.9%
Accounts Receivable, after Allowance for Credit Loss, Current 11.7B USD +2.03%
Inventory, Net 4.22B USD +4.02%
Assets, Current 33.8B USD +17.2%
Property, Plant and Equipment, Net 5.02B USD +1.62%
Operating Lease, Right-of-Use Asset 744M USD +0.95%
Intangible Assets, Net (Excluding Goodwill) 60.2B USD -4.17%
Goodwill 33.4B USD +3.61%
Other Assets, Noncurrent 9.2B USD +48.4%
Assets 142B USD +4.85%
Accounts Payable, Current 3.69B USD +25.7%
Employee-related Liabilities, Current 1.8B USD +31.4%
Liabilities, Current 41.9B USD +30%
Long-term Debt and Lease Obligation 58B USD +4.01%
Accrued Income Taxes, Noncurrent 2.18B USD -26.9%
Deferred Income Tax Liabilities, Net 2.73B USD +28.3%
Operating Lease, Liability, Noncurrent 735M USD -2.52%
Other Liabilities, Noncurrent 32.4B USD +0.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.51B USD -11.6%
Retained Earnings (Accumulated Deficit) -3.77B USD -311%
Stockholders' Equity Attributable to Parent 6.78B USD -47.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.82B USD -47.1%
Liabilities and Equity 142B USD +4.85%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.04B USD -3.65%
Net Cash Provided by (Used in) Financing Activities 10.8B USD
Net Cash Provided by (Used in) Investing Activities -9.59B USD -1821%
Common Stock, Shares Authorized 4B shares 0%
Common Stock, Shares, Issued 1.83B shares +0.46%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.25B USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.1B USD +49.9%
Deferred Tax Assets, Valuation Allowance 13.5B USD +40%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 19.9B USD +31.5%
Operating Lease, Liability 901M USD -2.07%
Depreciation 750M USD +0.54%
Payments to Acquire Property, Plant, and Equipment 193M USD +10.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 5.08B USD -47.3%
Lessee, Operating Lease, Liability, to be Paid 1.01B USD -2.23%
Property, Plant and Equipment, Gross 11.9B USD +5.17%
Operating Lease, Liability, Current 166M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169M USD +11.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -389M USD -45.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 107M USD -3.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 145M USD +11.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 200M shares 0%
Unrecognized Tax Benefits 5.76B USD +1.62%
Lessee, Operating Lease, Liability, to be Paid, Year Four 115M USD +1.77%
Amortization of Intangible Assets 7.69B USD -4.86%
Deferred Tax Assets, Net of Valuation Allowance 6.46B USD +16.7%
Share-based Payment Arrangement, Expense 821M USD +9.47%
Interest Expense 2.51B USD +12.3%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%